How do you choose between azithromycin and roflumilast in the management of a patient with severe COPD who remains symptomatic with frequent exacerbations despite maximal dose LABA/LAMA/ICS with demonstrated compliance and proper inhaler technique?
Answer from: at Community Practice
Zithromax 250 mg on Monday, Wednesday, and Friday. I would consider roflumilast only in patients who are phenotypically and physiologically chronic bronchitis patients.
Sign in or Register to read more